Albumin & Creatinine Tests Market Size

  • Report ID: 4665
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Albumin & Creatinine Tests Market Size

Albumin & Creatinine Tests Market size was over USD 4.25 billion in 2024 and is projected to reach USD 41.23 billion by 2037, witnessing around 19.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of albumin & creatinine tests is assessed at USD 5.65 billion.

The growth of the market can be attributed to the increasing cases of kidney diseases and disorders worldwide. Kidney disease is a serious medical condition that can lead to kidney failure. As per the Centers for Disease Control and Prevention (CDC), more than 1 in 7 adults i.e., 37 million people, suffered from chronic kidney disease in 2021. A variety of urine analysis procedures and products are available to detect such disease, which include multiple kidney treatments as well as regular blood examinations of components such as creatinine, albumin, and the ACR ratio. Urine analysis can provide information about the presence of kidney diseases. It can also help to monitor the progression of kidney diseases and assess the effectiveness of treatment.

Additionally, other factors that are anticipated to contribute to the growth of the global albumin tests and creatinine tests market include the increasing awareness of early disease detection among people and the growing preference for home testing for regular monitoring. Additionally, innovations in urine analysis testing is anticipated to contribute to the growth of the market. For instance, Minuteful Kidney is a smartphone-based, home kidney function testing service that is convenient and affordable. The test is easy to use and can be done at home without visiting a doctor. It can be done regularly to help people with diabetes or high blood pressure monitor their kidney health. The result of the patient's test is automatically recorded in the app's electronic medical record, and it is automatically sent to their healthcare practitioner for further action.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4665
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of albumin & creatinine tests is assessed at USD 5.65 billion.

The albumin & creatinine tests market size was over USD 4.25 billion in 2024 and is projected to reach USD 41.23 billion by 2037, witnessing around 19.1% CAGR during the forecast period i.e., between 2025-2037. Rising rates of hypoalbuminemia and hypovolemia and the rising geriatric population will boost the market growth.

North America industry is set to account for largest revenue share by 2037, attributed to increasing prevalence of chronic diseases and rise in healthcare spending by general population.

The major players in the market are Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers company, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample